News & Analysis as of

Manufacturers HELP

King & Spalding

Act II: The Senate Unveils Its Draft

King & Spalding on

On May 27, 2022, Senate Health, Education, Labor, and Pensions (“HELP”) Committee leaders introduced the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (“FDASLA Act of 2022”), which, if passed,...more

Akin Gump Strauss Hauer & Feld LLP

FDA Preparedness Reforms Come into Focus as the PREVENT Pandemics Act Advances in the Senate HELP Committee

Last month, the Senate Health, Education, Labor and Pensions (HELP) Committee voted 20 to 2 to advance S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats and Pandemics Act (the “PREVENT Pandemics...more

Mintz - Health Care Viewpoints

Looking Ahead: FDA in 2021

The U.S. Food and Drug Administration had a busy 2020, as detailed in earlier blog posts. This blog post explores politics and a few policy activities we’ll be keeping an eye on in 2021 and how they might impact medical...more

Mintz

Medical Device Updates: U.S. Food and Drug Administration (FDA) Practice Trends

Mintz on

Data and Analytics — FDA’s Post-market Surveillance Data Proposals Press Forward - FDA’s National Evaluation System for Health Technology, or NEST, as FDA calls it, is quickly gaining traction as one of the...more

King & Spalding

Senate HELP Committee Minority Staff Report Places Blame on Manufacturers, Hospitals, and FDA Regarding Duodenoscope-Linked...

King & Spalding on

On January 13, 2016, Senator Patty Murray (D-WA), Ranking Member of the United States Senate Health, Education, Labor, and Pensions (“HELP”) Committee, released a Minority Staff Report detailing the results of a year-long...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide